Page last updated: 2024-11-05

octachlorodibenzo-4-dioxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

octachlorodibenzo-4-dioxin: RN given refers to unlabeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18636
CHEMBL ID136461
CHEBI ID81566
SCHEMBL ID1954279
MeSH IDM0069356

Synonyms (54)

Synonym
dibenzo[b,e][1,4]dioxin, octachloro-
octachlorodibenzodioxin
octachlorodibenzo[b,4]dioxin
1,3,4,6,7,8,9-octachlorodibenzo-p-dioxin
ocdd
wln: t c666 bo ioj dg eg fg gg kg lg mg ng
dibenzo-p-dioxin,2,3,4,6,7,8,9-octachloro-
dibenzo[b,4]dioxin, octachloro-
nsc-37651
1,3,4,6,7,8,9-octachlorodibenzodioxin
octachlorodibenzo-p-dioxin
nci-c03678
nsc37651
dibenzo-p-dioxin, octachloro-
1,3,4,6,7,8,9-octachorodibenzo-p-dioxin
octachloro-p-dibenzodioxin
3268-87-9
dibenzo-p-dioxin, 1,2,3,4,6,7,8,9-octachloro-
1,2,3,4,6,7,8,9-octachorodibenzo-p-dioxin
nsc 37651
1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin
ccris 4687
1,2,3,4,6,7,8,9-octachlorodibenzo(1,4)dioxin
brn 0356027
octachloro-para-dibenzodioxin
dibenzo(b,e)(1,4)dioxin, octachloro-
1,2,3,4,6,7,8,9-octachlorodibenzodioxin
1,2,3,4,6,7,8,9-octachlorodibenzo(b,e)(1,4)dioxin
octachlorodibenzo(b,e)(1,4)dioxin
hsdb 6480
octachlorodibenzo-4-dioxin
octachlorooxanthrene
octachlorodibenzodioxin (ocdd)
chebi:81566 ,
CHEMBL136461 ,
1,2,3,4,6,7,8,9-octachloro-dibenzo[1,4]dioxine
C18180
pcdd 75
unii-yw59p10266
yw59p10266 ,
1,2,3,4,6,7,8,9-dibenzo-p-dioxin
bdbm50408295
FT-0673177
e)(1,4)dioxindibenzo(b octachloro-
dibenzo(b,e)(1,4)dioxin, 1,2,3,4,6,7,8,9-octachloro-
octachlorodibenzo-p-dioxin [hsdb]
SCHEMBL1954279
1,2,3,4,6,7,8,9-octachlorooxanthrene #
1,2,3,4,6,7,8,9-octachlorodibenzo[1,4]dioxin
FOIBFBMSLDGNHL-UHFFFAOYSA-N
DTXSID4025799
J-018835
perchlorodibenzo[b,e][1,4]dioxine
Q7076685

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" We do not expect to find adverse effects of these compounds on the aquatic environment."( Bioaccumulation and lack of toxicity of octachlorodibenzofuran (OCDF) and octachlorodibenzo-p-dioxin (OCDD) to early-life stages of zebra fish (Brachydanio rerio).
Berends, AG; Boelhouwers, EJ; de Gerlache, J; de Rooij, CG; Thus, JL, 1997
)
0.3

Dosage Studied

ExcerptRelevanceReference
" One gram of chromic oxide (Cr2O3) was administered as a digestion marker to dosed calves."( Uptake and excretion of organochlorine compounds in neonatal calves.
Borger, DC; Keller, HL; Willett, LB, 2001
)
0.31
"There were striking dose-response relations between serum concentrations of six selected POPs and the prevalence of diabetes."( A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002.
Baker, BA; Jacobs, DR; Lee, DH; Lee, IK; Song, K; Steffes, M; Toscano, W, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
polychlorinated dibenzodioxineAny dibenzodioxine in which two or more hydrogens have been replaced by chlorines.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A1Rattus norvegicus (Norway rat)EC50 (µMol)10.00000.00152.205710.0000AID39064
Aryl hydrocarbon receptorHomo sapiens (human)EC50 (µMol)10.00000.00151.976910.0000AID39064
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (22)

Processvia Protein(s)Taxonomy
blood vessel developmentAryl hydrocarbon receptorHomo sapiens (human)
regulation of adaptive immune responseAryl hydrocarbon receptorHomo sapiens (human)
negative regulation of T cell mediated immune response to tumor cellAryl hydrocarbon receptorHomo sapiens (human)
regulation of DNA-templated transcriptionAryl hydrocarbon receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIAryl hydrocarbon receptorHomo sapiens (human)
xenobiotic metabolic processAryl hydrocarbon receptorHomo sapiens (human)
apoptotic processAryl hydrocarbon receptorHomo sapiens (human)
response to xenobiotic stimulusAryl hydrocarbon receptorHomo sapiens (human)
response to toxic substanceAryl hydrocarbon receptorHomo sapiens (human)
regulation of gene expressionAryl hydrocarbon receptorHomo sapiens (human)
cAMP-mediated signalingAryl hydrocarbon receptorHomo sapiens (human)
intracellular receptor signaling pathwayAryl hydrocarbon receptorHomo sapiens (human)
regulation of B cell proliferationAryl hydrocarbon receptorHomo sapiens (human)
circadian regulation of gene expressionAryl hydrocarbon receptorHomo sapiens (human)
negative regulation of DNA-templated transcriptionAryl hydrocarbon receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionAryl hydrocarbon receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAryl hydrocarbon receptorHomo sapiens (human)
negative regulation of inflammatory responseAryl hydrocarbon receptorHomo sapiens (human)
cellular response to molecule of bacterial originAryl hydrocarbon receptorHomo sapiens (human)
cellular response to cAMPAryl hydrocarbon receptorHomo sapiens (human)
cellular response to forskolinAryl hydrocarbon receptorHomo sapiens (human)
cellular response to 2,3,7,8-tetrachlorodibenzodioxineAryl hydrocarbon receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
nuclear receptor activityAryl hydrocarbon receptorHomo sapiens (human)
transcription cis-regulatory region bindingAryl hydrocarbon receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificAryl hydrocarbon receptorHomo sapiens (human)
cis-regulatory region sequence-specific DNA bindingAryl hydrocarbon receptorHomo sapiens (human)
TFIID-class transcription factor complex bindingAryl hydrocarbon receptorHomo sapiens (human)
transcription coactivator bindingAryl hydrocarbon receptorHomo sapiens (human)
DNA bindingAryl hydrocarbon receptorHomo sapiens (human)
DNA-binding transcription factor activityAryl hydrocarbon receptorHomo sapiens (human)
nuclear receptor activityAryl hydrocarbon receptorHomo sapiens (human)
protein bindingAryl hydrocarbon receptorHomo sapiens (human)
TBP-class protein bindingAryl hydrocarbon receptorHomo sapiens (human)
protein homodimerization activityAryl hydrocarbon receptorHomo sapiens (human)
protein heterodimerization activityAryl hydrocarbon receptorHomo sapiens (human)
Hsp90 protein bindingAryl hydrocarbon receptorHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingAryl hydrocarbon receptorHomo sapiens (human)
E-box bindingAryl hydrocarbon receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingAryl hydrocarbon receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
nucleusAryl hydrocarbon receptorHomo sapiens (human)
nuclear aryl hydrocarbon receptor complexAryl hydrocarbon receptorHomo sapiens (human)
nucleusAryl hydrocarbon receptorHomo sapiens (human)
nucleoplasmAryl hydrocarbon receptorHomo sapiens (human)
cytoplasmAryl hydrocarbon receptorHomo sapiens (human)
cytosolAryl hydrocarbon receptorHomo sapiens (human)
chromatinAryl hydrocarbon receptorHomo sapiens (human)
transcription regulator complexAryl hydrocarbon receptorHomo sapiens (human)
protein-containing complexAryl hydrocarbon receptorHomo sapiens (human)
cytosolic aryl hydrocarbon receptor complexAryl hydrocarbon receptorHomo sapiens (human)
aryl hydrocarbon receptor complexAryl hydrocarbon receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID39064Affinity on cytosolic Aromatic hydrocarbon receptor (Ah)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.86)18.7374
1990's6 (17.14)18.2507
2000's17 (48.57)29.6817
2010's11 (31.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.63 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies1 (2.78%)4.05%
Observational0 (0.00%)0.25%
Other34 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]